Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases
Devon E. McMahonMassachusetts General HospitalErin AmersonDepartment of Dermatology, University of California San Francisco, San Francisco, CaliforniaMisha RosenbachDepartment of Dermatology, University of Pennsylvania, Philadelphia, PennsylvaniaJules B. LipoffDepartment of Dermatology, University of Pennsylvania, Philadelphia, PennsylvaniaDanna MoustafaMassachusetts General HospitalAnisha TyagiMassachusetts General HospitalSeemal R. DesaiInnovative Dermatology, Plano, TexasLars E. FrenchDepartment of Dermatology, University Hospital, Munich University of Ludwig Maximilian, Munich, Germany; Dr. Philip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FloridaHenry W. LimDepartment of Dermatology, Henry Ford Health System, Detroit, MichiganB.H. ThiersDepartment of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, South CarolinaGeorge J. HruzaDepartment of Dermatology, St. Louis University, St. Louis, MissouriKimberly G. BlumenthalDivision of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MassachusettsLindy P. FoxDepartment of Dermatology, University of California San Francisco, San Francisco, CaliforniaEsther E. FreemanMedical Practice Evaluation Center, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts
2021en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba